This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, provides a range of pharmaceutical products and medical supplies to the U.S. Department of Defense (DoD) and Department of Veterans Affairs (VA). The award, valued at $2,169.08, is a firm fixed-price delivery order under the Defense Logistics Agency's (DLA) SPE2DB program, a large indefinite delivery contract (IDC) worth up to $499,999,999 that runs through December 31, 2025. This IDC allows the DLA to issue delivery orders for a comprehensive array of pharmaceutical items, from common medications to specialized drugs and supplies, to support the diverse medical needs of military personnel and their dependents across DoD healthcare facilities. The specific items provided under this award include dextroamphetamine-amphetamine 5 mg tablets. This contract has no set-aside designation.
Generated 12/24/24, 9:12 AM